Accent Microcell Limited

Accent Microcell Limited (ACCENTMIC) is a micro-cap Healthcare company valued at ₹1,620 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Accent Microcell Limited last traded at ₹675, modestly down 1.89% on the day.

Recent developments

On 2026-08-13, Accent Microcell placed an order for a 4.45 MW wind turbine generator from Inox Wind, signaling a shift towards using renewable energy to manage manufacturing costs.

Financial performance

The company's business is improving, with annual revenue rising 31.7% and annual net profit growing 32.9%. The latest quarter saw revenue and net profit both surge 51.1% and 52.9% respectively compared to the same quarter a year earlier. Margins have slightly improved, with the net profit margin rising 0.1 percentage points to 12.6%, while returns remain strong with return on equity at 15.9% and return on capital employed at 21.3%.

Valuation multiples

The stock trades at 36.2 times earnings, broadly in line with the Healthcare median of 32.0, 6.16 times book value. It yields 0.1%.

Things to watch

The company's promoter holding fell by 2.45 percentage points in the quarter, raising concerns about ownership stability. The stock is currently 8.4% below its 52-week high, indicating a potential pullback from recent peak levels.

Where it stands

Accent Microcell has delivered strong growth in both revenue and profit over the past year and quarter, with margins and returns remaining robust. The most significant movement was the 52.9% rise in net profit in the latest quarter. The company's promoter holding has declined, and the stock is trading below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.